PTEN在CCl4诱导肝纤维化大鼠模型中的作用及益气活血方对其的影响

牛学敏; 王宝玉; 王洋; 赵文; 付娜; 赵素贤; 杜静华; 王荣琦; 张玉果; 南月敏

doi:10.3969/j.issn.1001-5256.2018.01.025

PTEN在CCl4诱导肝纤维化大鼠模型中的作用及益气活血方对其的影响

DOI: 10.3969/j.issn.1001-5256.2018.01.025

河北医科大学第三医院中西医结合肝病科

基金项目:

河北省中医药慢性丙型肝炎气虚血瘀证重点实验室(2014)； 2014年、2016年河北政府资助省级临床医学优秀人才项目研究；

详细信息

中图分类号: R285.5;R-332
计量
- 文章访问数: 2391
- HTML全文浏览量: 53
- PDF下载量: 526
- 被引次数: 0
出版历程
- 出版日期: 2018-01-20

Role of phosphatase and tensin homolog deleted on chromosome ten in a rat model of carbon tetrachloride-induced liver fibrosis and the effect of qi-tonifying and blood-activating prescription

Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang 050051, China

Research funding:

摘要

摘要:
目的探讨第10号染色体缺失性磷酸酶张力蛋白同原物基因（PTEN）在CCl4诱导肝纤维化大鼠模型中的作用,阐明益气活血方调节PTEN阻止肝纤维化的分子机制。方法选用27只Wistar雄性大鼠,随机分为3组,每组9只。其中肝纤维化组以CCl4诱导建立肝纤维化模型;益气活血方组在CCl4造模同时自拟以黄芪、丹参、云苓等中药为主的益气活血方进行干预实验;对照组以橄榄油腹腔注射。HE染色、Masson染色及胶原（Col1A1和Col4）免疫组化染色观察不同组别大鼠肝纤维化及胶原沉积程度;qRT-PCR、免疫组化及Western Blot检测TGFβ1、PTEN及其下游基因AKT、mTOR及p70S6K表达。计量资料多组间比较采用单因素方差分析,进一步两两比较采用LSD-t检验。结果肝纤维化组大鼠肝组织病理学可见窦周纤维化、汇管区纤维组织增生及胶原沉积、纤维间隔形成,伴随促肝纤维化基因TGFβ1 mRNA及蛋白表达上调,PTEN表达下调,而PTEN下游信号因子AKT、mTOR、p70S6K mRNA及磷酸化蛋白表达上调,与对照组比较...
- 肝硬化 /
- PTEN /
- 益气活血 /
- 大鼠,Wistar
Abstract:
Objective To investigate the role of phosphatase and tensin homology deleted on chromosome ten ( PTEN) in a rat model of carbon tetrachloride ( CCl4) -induced liver fibrosis and the molecular mechanism of action of qi-tonifying and blood-activating prescription in regulating PTEN and inhibiting liver fibrosis. Methods A total of 27 male Wistar rats were randomly divided into three groups, with 9 rats in each group. The rats in liver fibrosis group were treated with CCl4 to establish a model of liver fibrosis, and those in qi-tonifying and blood-activating prescription group were also treated with CCl4 to establish a model and then given a self-made qi-tonifying and blood-activating prescription containing Astragalus membranaceus, Salvia miltiorrhiza, and poria. The rats in the control group were given intraperitoneally injected olive oil. HE staining, Masson staining, and immunohistochemical staining of collagen type I alpha 1 ( Col1 A1) and collagen type Ⅳ ( Col4) were performed to observe the degree of liver fibrosis and collagen deposition; qRT-PCR, immunohistochemistry, and Western blot were used to measure the expression of transforming growth factor-β1 ( TGF-β1) , PTEN, and downstream genes AKT, mTOR, and p70 S6 K. A one-way analysis of variance was used for comparison of continuous data between multiple groups and the least significant difference t-test was used for further comparison between any two groups. Results In the liver fibrosis group, liver pathology showed perisinusoidal fibrosis and fibrous tissue proliferation, collagen deposition, and formation of fibrous septum in the portal area; compared with the control group, the liver fibrosis group had significant increases in the mRNA and protein expression of TGF-β1, a significant reduction in the expression of PTEN, and significant increases in the mRNA and phosphorylated protein expression of AKT, mTOR, and p70 S6 K ( all P < 0. 01) . The qi-tonifying and blood-activating prescription group had a marked improvement in liver fibrosis; compared with the liver fibrosis group, the qi-tonifying and blood-activating prescription group had a significant increase in the expression of PTEN ( P < 0. 01) , significantly inhibited mRNA and protein expression of TGF-β1 ( both P < 0. 05) , and significant reductions in the mRNA and phosphorylated protein expression of AKT, mTOR, and p70 S6 K ( all P < 0. 05) . Conclusion Qi-tonifying and blood-activating prescription can prevent and reverse liver fibrosis, possibly by regulating the expression of PTEN and its downstream signal factors.
- liver cirrhosis /
- phosphatase and tensin homology deteted on chromosome ten /
- REINFORCING QI ACTIVAT BLOOD /
- rats, Wistar

HTML全文

参考文献(22)

[1]ZHOU WC, ZHANG QB, QIAO L, et al.Pathogenesis of liver cirrhosis[J].World J Gastroenterol, 2014, 20 (23) :7312-7324.

[2]ARRIAZU E, RUIZ de GALARRETA M, CUBERO FJ, et al.Extracellular matrix and liver disease[J].Antioxid Redox Signal, 2014, 21 (7) :1078-1097.

[3]FRIEDMAN SL.Hepatic stellate cells:protean, multifunctional, and enigmatic cells of the liver[J].Physiol Rev, 2008, 88 (1) :125-172.

[4]ZHANG JQ, HAO LS.The research progress of PTEN in liver fibrosis diseases[J/CD].J World Latest Med Inf:Electronic Version, 2016, 16 (14) :83-85, 88. (in Chinese) 张家琪, 郝礼森.PTEN在肝纤维化疾病中的研究进展[J/CD].世界最新医学信息文摘:连续型电子期刊, 2016, 16 (14) :83-85, 88.

[5]AN J, ZHENG L, XIE S, et al.Regulatory effects and mechanism of adenovirus-mediated PTEN gene on hepatic stellate cells[J].Dig Dis Sc, 2016, 61 (4) :1107-1120.

[6]ZHAO XY, WANG BE, LI XM, et al.Newly proposed fibrosis staging criterion for assessing carbon tetrachloride-and albumin complex-induced liver fibrosis in rodents[J].Pathol Int, 2008, 58 (9) :580-588.

[7]WANG Q, WEN R, LIN Q, et al.Wogonoside shows antifibrotic effects in an experimental regression model of hepatic fibrosis[J].Dig Dis Sci, 2015, 60 (11) :3329-3339.

[8]SHEN GW, LI Q, LIU Y.Danji Huoxue decoction on serum inflammatory and liver fibrosis degradation indexes in hepatitis B patients with cirrhosis[J].J Changchun Univ Chin Med, 2016, 32 (6) :1188-1190. (in Chinese) 申广文, 李强, 刘颖.丹鸡活血汤对乙型肝炎肝硬化患者血清炎症指标及肝纤维化降解指标的影响[J].长春中医药大学学报, 2016, 32 (6) :1188-1190.

[9]SFERRA R, VETUSCHI A, CATITTI V, et al.Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation[J].Eur Rev Med Pharmacol Sci, 2012, 16 (11) :1484-1498.

[10]LI J, YE J, XUE DY, et al.Study on inhibition and mechanism of Guizhi Fuling Wan on hepatic fibrosis rats[J].Chin J Exp Med Formul, 2011, 17 (24) :171-175. (in Chinese) 李季, 叶军, 薛冬英, 等.桂枝茯苓丸抗大鼠肝纤维化作用及其机制研究[J].中国实验方剂学杂志, 2011, 17 (24) :171-175.

[11]ZHOU YX, CHEN J, LI JP, et al.Chinese medicinal herbs in treating model rats with hepatic fibrosis[J].Afr J Tradit Complement Altern Med, 2009, 7 (2) :104-108.

[12]KIM HG, HAN JM, LEE JS, et al.Ethyl acetate fraction of Amomum xanthioides improves bile duct ligation-induced liver fibrosis of rat model via modulation of pro-fibrogenic cytokines[J].Sci Rep, 2015, 5:14531.

[13]WANG BY, ZHAO W, NIU XM, et al.Mechanism of action of Yiqi Huoxue Recipe in regulating autophagy and reversing liver fibrosis[J].Chin J Hepatol, 2017, 25 (5) :365-370. (in Chinese) 王宝玉, 赵文, 牛学敏.等.益气活血方调节自噬及逆转肝纤维化机制的研究[J].中华肝脏病杂志, 2017, 25 (5) :365-370.

[14]TAKASHIMA M, PARSONS CJ, IKEJIMA K, et al.The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation[J].J Gastroenterol, 2009, 44 (8) :847-855.

[15]NIU X, FU N, DU J, et al.miR-1273g-3p modulates activation and apoptosis of hepatic stellate cells by directly targeting PTEN in HCV-related liver fibrosis[J].FEBS Lett, 2016, 590 (16) :2709-2724.

[16]HAO LS, ZHANG XL, REN CZ, et al.Overexpression of thetumor suppressor gene PTEN inhibits the phosphorylation of Akt in activated hepatic stellate cells in vitro[J].J Pract Med, 2014, 30 (7) :1069-1072. (in Chinese) 郝礼森, 张晓岚, 任昌镇, 等.PTEN过表达抑制体外活化肝星状细胞Akt的磷酸化[J].实用医学杂志, 2014, 30 (7) :1069-1072.

[17]MATSUDA S, KOBAYASHI M, KITAGISHI Y.Roles for PI3K/AKT/PTEN pathway in cell signaling of nonalcoholic fatty liver disease[J].ISRN Endocrinol, 2013, 2013:472432.

[18]BIAN EB, HUANG C, MA TT, et al.DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats[J].Toxicol Appl Pharmacol, 2012, 264 (1) :13-22.

[19]LI WX, CHEN X, YANG Y, et al.Hesperitin derivative-11 suppress hepatic stellate cell activation and proliferation by targeting PTEN/AKT pathway[J].Toxicology, 2017, 381:75-86.

[20]PERL A.mT OR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging[J].Ann N Y Acad Sci, 2015, 1346 (1) :33-44.

[21]WU CH, SHEN M, LI L, et al.Assocciation between PI3K/Akt/mT OR/p70S6K signaling pathway and hepatic fibrosis[J].J ClinHepatol, 2015, 31 (11) :1928-1932. (in Chinese) 吴长会, 沈敏, 李龙, 等.PI3K/Akt/mT OR/p70S6K信号通路在肝纤维化发生发展中的作用[J].临床肝胆病杂志, 2015, 31 (11) :1928-1932.

[22]ZHAN SX, HUANG C, MA TT, et al.The study on the effect of silencing p70S6K on the proliferation and activation of HSC-T6[J].Acta Univ Med Anhui, 2014, 49 (8) :1062-1067. (in Chinese) 占书箱, 黄成, 马陶陶, 等.抑制p70S6K对HSC-T6增殖活化的作用研究[J].安徽医科大学学报, 2014, 49 (8) :1062-1067.

施引文献

资源附件(0)

访问统计